1-4 of 4
Taro Amagasaki, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessing the Safety and Efficacy of Ruxolitinib in a Multicenter, Open-Label, Expanded-Access Study in Japanese Patients with Myelofibrosis (MF)

Keita Kirito, MD, Norio Komatsu, MD PhD, Kazuya Shimoda, MD PhD, Hikaru Okada, MD PhD, Taro Amagasaki, PhD, Toshio Yonezu, MSc, Koichi Akashi, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1625.
https://doi.org/10.1182/blood.V126.23.1625.1625
Published: 2015
Journal Articles

Nilotinib Following Molecular Suboptimal Response (SoR) To Imatinib In Japanese Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP): 12 Month Follow-Up From The SENSOR Study

Koichi Miyamura, MD, PhD, Toshihiro Miyamoto, MD, Mineo Kurokawa, MD, PhD, Mitsune Tanimoto, MD, PhD, Kazuhito Yamamoto, M.D., Ph.D., Masafumi Taniwaki, MD, PhD, Shinya Kimura, MD, PhD, Kazuma Ohyashiki, MD, PhD, Tatsuya Kawaguchi, MD, PhD, Itaru Matsumura, MD, PhD, Tomoko Hata, MD, PhD, Hisashi Tsurumi, MD, PhD, Shigeki Saito, MD, PhD, Masayuki Hino, MD, PhD, Seiji Tadokoro, Kuniaki Meguro, M.D., Ph.D., Hideo Hyodo, MD, Masahide Yamamoto, MD, Kohmei Kubo, MD, Junichi Tsukada, Midori Kondo, Taro Amagasaki, PhD, Eiji Kawahara, PhD, Masamitsu Yanada
Journal: Blood
Blood (2013) 122 (21): 2729.
https://doi.org/10.1182/blood.V122.21.2729.2729
Published: 2013
Journal Articles

A Multinational, Open-Label Phase 2 Study Of Ruxolitinib In Asian Patients (Pts) With Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (PPV-MF), Or Post–Essential Thrombocythemia MF (PET-MF)

Chul Won Jung, MD, PhD, Lee-Yung Shih, MD, Zhijian Xiao, MD, Jie Jin, MD, Hsin-An Hou, MD, Xin Du, MD, Ming-Chung Wang, MD, Seonyang Park, MD, PhD, Ki-Seong Eom, MD, PhD, Kenji Oritani, Shinichiro Okamoto, MD, PhD, Tetsuzo Tauchi, MD, Jin Seok Kim, MD, Daobin Zhou, MD, Andres Sirulnik, MD, PhD, Wanda Ruiz, PhD, Taro Amagasaki, PhD, Kazuo Ito, Koichi Akashi, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4086.
https://doi.org/10.1182/blood.V122.21.4086.4086
Published: 2013
Journal Articles

Safety and Pharmacokinetics of Ruxolitinib (INC424) in Healthy Japanese Volunteers: Placebo-Controlled, Double-Blind, Dose-Escalation Phase 1 Study

Yoichiro Ogama, MD, PhD, Tomoko Mineyame, Asuka Yamamoto, Naomi Shimada, Taro Amagasaki, PhD, Kazuto Natsume
Journal: Blood
Blood (2011) 118 (21): 5162.
https://doi.org/10.1182/blood.V118.21.5162.5162
Published: 2011